Let’s start with the medical miracle and the man who benefitted from it. His name is Daniel Cressy. He is one of more than ...
I'm Larry Biegelsen, the Medical Device Analyst at Wells Fargo. Welcome to the final call in our 2026 MedTech Innovation Spotlight Series. I'm pleased to be joined by Inspire Medical's management team ...
Erik Steiger discusses the operational pain of legacy PDF generation in regulated banking and manufacturing. He explains how ...
The Hearty Soul on MSN
Four jobs will survive AI takeover, Bill Gates says
Bill Gates named coders, biologists, energy workers, and athletes as jobs likely to survive AI. The post Bill Gates Says Only ...
The Hearty Soul on MSN
AI is on the verge of escaping human control - and nobody has a plan yet
AI control risks are accelerating in 2026 as agentic systems outpace oversight. Here's what the latest research and Google ...
Introduction Psychotic disorders account for significant morbidity and healthcare costs and yet their pathophysiology remains poorly understood. The National Institute for Health and Care Research ...
The mid-revenue cycle is where medicine, documentation, and coding converge to produce the record that determines reimbursement, risk adjustment metrics, and quality scores. Physicians make the ...
The Goldman Sachs GQG Partners International Opportunities Fund significantly outperformed its benchmark in 1Q26 amid energy ...
This study evaluated whether adherence to a hypertension quality measure correlates with actual blood pressure control. Findings reveal misalignment between adherence metrics and clinical outcomes.
Lu]Lu-edotreotide led to statistically significant and clinically meaningful improvements in progression-free survival. Efficacy and harms results support the use of [177Lu]Lu-edotreotide in early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results